
Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures. Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, Volta AF-Xplorer, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With Volta AF-Xplorer, operators keep their go-to navigation system and catheters. The Volta AF-Xplorer real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation. Volta AF-Xplorer is CE marked and FDA cleared. Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.

Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures. Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, Volta AF-Xplorer, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With Volta AF-Xplorer, operators keep their go-to navigation system and catheters. The Volta AF-Xplorer real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation. Volta AF-Xplorer is CE marked and FDA cleared. Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.
Founded: June 2016
Headquarters: Marseille, France
Sector: AI-driven medical software for interventional cardiology (electrophysiology)
Flagship product: Volta AF-Xplorer (CE marked and FDA cleared)
Recent financing: Series B led by Vensana Capital (announced Jan 2023)
| Company |
|---|
Interventional cardiac electrophysiology—identification and interpretation of intra-cardiac electrograms during ablation procedures.
2016
Medical Equipment Manufacturing
“Vensana Capital, Lightstone Ventures, Gilde Healthcare, Groupe Pasteur Mutualité”